METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR AUTOMIMMUNE SYSTEM CONDITIONS

Patent №

US 10,073,952

Granted

2018-09-11

Filed 2016

Owner

UBIOME, INC.

Lab

AI components

5

ml · nlp · kr · planning · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

15098027

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

Machine learningNatural languageKnowledge representationPlanningAI hardwareG16H 50/20G16B 35/00G16B 40/00G16B 40/20G16B 50/00G16B 50/10G16C 20/60G16H 40/67+2 more

AI classification

Planning1.00
AI hardware0.98
Machine learning0.98
Knowledge representation0.93
Natural language0.76
Vision0.47
Evolutionary computation0.30
Speech0.00

Ownership

UBIOME, INC.

assignment · 384810018

Assignors

APTE, ZACHARY, ALMONACID, DANIEL, RICHMAN, JESSICA, BELBAHANI, SIAVOSH REZVAN

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC